<SEC-DOCUMENT>0001193125-19-161324.txt : 20190530
<SEC-HEADER>0001193125-19-161324.hdr.sgml : 20190530
<ACCEPTANCE-DATETIME>20190530162508
ACCESSION NUMBER:		0001193125-19-161324
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20190530
DATE AS OF CHANGE:		20190530
EFFECTIVENESS DATE:		20190530

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MEDNAX, INC.
		CENTRAL INDEX KEY:			0000893949
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-HOSPITALS [8060]
		IRS NUMBER:				263667538
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-231826
		FILM NUMBER:		19866844

	BUSINESS ADDRESS:	
		STREET 1:		1301 CONCORD TERRACE
		CITY:			SUNRISE
		STATE:			FL
		ZIP:			33323
		BUSINESS PHONE:		9543840175

	MAIL ADDRESS:	
		STREET 1:		1301 CONCORD TERRACE
		CITY:			SUNRISE
		STATE:			FL
		ZIP:			33323

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PEDIATRIX MEDICAL GROUP INC
		DATE OF NAME CHANGE:	19950801
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>d754061ds8.htm
<DESCRIPTION>S-8
<TEXT>
<HTML><HEAD>
<TITLE>S-8</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As filed with the Securities and Exchange Commission on May&nbsp;30, 2019 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Registration
<FONT STYLE="white-space:nowrap">No.&nbsp;333-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> </B></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES
AND EXCHANGE COMMISSION </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>WASHINGTON, DC 20549 </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT
STYLE="white-space:nowrap">S-8</FONT> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>REGISTRATION STATEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>UNDER </I></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>THE
SECURITIES ACT OF 1933 </I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>MEDNAX, INC. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name
of registrant as specified in its charter) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Florida</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">26-3667538</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>incorporation or organization)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(IRS Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>1301 Concord Terrace </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sunrise, Florida 33323 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of Principal Executive Offices) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MEDNAX, Inc. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Amended and
Restated 2008 Incentive Compensation Plan </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Full title of the plan) </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Dominic J. Andreano, Esq. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Senior Vice President, </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>General Counsel and Secretary </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MEDNAX, Inc. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>1301
Concord Terrace </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sunrise, Florida 33323 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name and address of agent for service) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(954) <FONT STYLE="white-space:nowrap">384-0175</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Telephone number, including area code, of agent for service) </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Copies to: </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Joshua
M. Samek, Esq. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DLA Piper LLP (US) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>200 South Biscayne Boulevard </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Suite 2500 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Miami,
Florida 33131-5341 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(305) 702-8880 </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether
the registrant is a large accelerated filer, an accelerated filer, a <FONT STYLE="white-space:nowrap">non-accelerated</FONT> filer, a smaller reporting company or an emerging growth company. See the definitions of &#147;large accelerated
filer,&#148; &#147;accelerated filer,&#148; &#147;smaller reporting company&#148; and &#147;emerging growth company&#148; in Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> of the Exchange Act. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="16%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="60%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Large&nbsp;accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Non-accelerated filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Smaller&nbsp;reporting&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Emerging&nbsp;growth&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;7(a)(2)(B) of the Securities Act.&nbsp;&nbsp;&#9744; </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CALCULATION OF
REGISTRATION FEE </B></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="44%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD></TR>


<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><B>Title of securities<BR>to be registered</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Amount<BR>to be</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>registered (1)</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Proposed</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>maximum<BR>offering price<BR>per share (2)</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><B>Proposed maximum<BR>aggregate offering<BR>price (2)</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><B>Amount of<BR>registration fee</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common Stock, $0.01 par value, to be issued under the MEDNAX,
Inc. Amended and Restated 2008 Incentive Compensation Plan</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">8,275,000</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$24.79</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$205,137,250</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$24,862.63</TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
</TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Pursuant to Rule 416 of the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), this
registration statement shall also cover any additional shares of common stock, $0.01 par value (the &#147;Common Stock&#148;), of MEDNAX, Inc. (the &#147;Registrant&#148;) which become issuable under the MEDNAX, Inc. Amended and Restated 2008
Incentive Compensation Plan by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the receipt of consideration which results in an increase in the number of our outstanding shares of Common
Stock. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Estimated solely for the purpose of calculating the registration fee in accordance with Rules 457(c) and
(h)&nbsp;of the Securities Act on the basis of the average of the high and low price of a share of Common Stock as reported by the New York Stock Exchange on May&nbsp;29, 2019. </P></TD></TR></TABLE>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXPLANATORY NOTE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Registration Statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-8</FONT> is being filed by MEDNAX, Inc., a Florida corporation
(the &#147;Registrant&#148;), for the purpose of registering an additional 8,275,000&nbsp;shares of its common stock, $0.01 par value (&#147;Common Stock&#148;), issuable pursuant to the MEDNAX, Inc. Amended and Restated 2008 Incentive Compensation
Plan (the &#147;Plan&#148;), for which previously filed Registration Statements on <FONT STYLE="white-space:nowrap">Form&nbsp;S-8</FONT> (File <FONT STYLE="white-space:nowrap">Nos.&nbsp;333-151272</FONT> and
<FONT STYLE="white-space:nowrap">333-181667)</FONT> are effective (the &#147;Prior Registration Statements&#148;). Pursuant to Instruction&nbsp;E of <FONT STYLE="white-space:nowrap">Form&nbsp;S-8,</FONT> the contents of the Prior Registration
Statements, as filed with the Securities and Exchange Commission on May&nbsp;30, 2008 and May&nbsp;24, 2012, respectively, as amended, are incorporated herein by reference. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Part I. INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information specified by Items 1 and 2 of Part I of <FONT STYLE="white-space:nowrap">Form&nbsp;S-8</FONT> is omitted from this filing in
accordance with the provisions of Rule&nbsp;428 of the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), and the introductory Note to Part&nbsp;I of <FONT STYLE="white-space:nowrap">Form&nbsp;S-8.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The documents containing the information specified in Part&nbsp;I of <FONT STYLE="white-space:nowrap">Form&nbsp;S-8</FONT> will be sent or
given to participants in the Plan as specified by Rule&nbsp;428(b) of the Securities Act. Such documents and the documents incorporated by reference herein pursuant to Item&nbsp;3 of Part&nbsp;II hereof, taken together, constitute a prospectus with
respect to the Plan that meets the requirements of Section&nbsp;10(a) of the Securities Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">I-1</FONT> </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Part II. INFORMATION REQUIRED IN THE REGISTRATION STATEMENT </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;3. Incorporation of Documents by Reference. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following documents, which have been filed with the Securities and Exchange Commission (the &#147;SEC&#148;), are hereby incorporated by
reference into this registration statement: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Registrant&#146;s Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/893949/000119312519040891/d671465d10k.htm">
<FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT></A> for the fiscal year ended December&nbsp;31, 2018; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Registrant&#146;s Quarterly Report on <A HREF="http://www.sec.gov/Archives/edgar/data/893949/000119312519135054/d709210d10q.htm">
<FONT STYLE="white-space:nowrap">Form&nbsp;10-Q</FONT></A> for the quarter ended March&nbsp;31, 2019; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Registrant&#146;s Current Reports on <FONT STYLE="white-space:nowrap">Form&nbsp;
8-K</FONT> filed on <A HREF="http://www.sec.gov/Archives/edgar/data/893949/000119312519047118/d706467d8k.htm">February&nbsp;21, 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/893949/000119312519089230/d929503d8k.htm">March&nbsp;28,
2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/893949/000119312519092716/d687635d8k.htm">March&nbsp;29, 2019</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/893949/000119312519150702/d751653d8k.htm">May&nbsp;17, 2019</A> (not
including any information furnished under Item 9.01 of any such Form <FONT STYLE="white-space:nowrap">8-K);</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Registrant&#146;s Proxy Statement on <A HREF="http://www.sec.gov/Archives/edgar/data/893949/000119312519092753/d716213ddef14a.htm">Schedule&nbsp;14A
</A> filed on March&nbsp;29, 2019; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The description of the Registrant&#146;s common stock contained in the Registration Statement on <A HREF="http://www.sec.gov/Archives/edgar/data/893949/0000950170-96-000727.txt">
<FONT STYLE="white-space:nowrap">Form&nbsp;8-A</FONT></A> (Registration <FONT STYLE="white-space:nowrap">No.&nbsp;001-12111)</FONT> filed with the SEC on September&nbsp;4, 1996 by Pediatrix Medical Group, Inc., a Florida corporation and the
Registrant&#146;s predecessor, and any amendments to such Registration Statement filed subsequently thereto, including all amendments or reports filed for the purpose of updating such description. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, all documents subsequently filed by us pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act (not including any
information furnished under Items 2.02, 7.01 or 9.01 of Form <FONT STYLE="white-space:nowrap">8-K,</FONT> which information is not incorporated by reference herein) prior to the filing of a post-effective amendment which indicates that all
securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated herein by reference and to be a part of this registration statement from the date of filing of such documents. Any
statement contained in a document incorporated herein by reference will be deemed to be modified or superseded for purposes of this registration statement to the extent that a statement contained herein, or in a subsequently filed document
incorporated herein by reference, modifies or supersedes the statement. Any statement modified or superseded will not be deemed, except as modified or superseded, to constitute a part of this registration statement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;4. Description of Securities. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;5. Interests of
Named Experts and Counsel. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The validity of the securities being registered hereunder is being passed upon for us by DLA Piper LLP
(US), Miami, Florida. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">II-1</FONT> </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;6. Indemnification of Directors and Officers. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a corporation incorporated in the State of Florida, we are subject to the Florida Business Corporation Act, or the Florida Act.
Section&nbsp;607.0831 of the Florida Act provides that a director is not personally liable for monetary damages to the corporation or any other person for any statement, vote, decision, or failure to act regarding corporate management or policy
unless (1)&nbsp;the director breached or failed to perform his or her duties as a director and (2)&nbsp;the director&#146;s breach of, or failure to perform, those duties constitutes (a)&nbsp;a violation of the criminal law, unless the director had
reasonable cause to believe his or her conduct was lawful or had no reasonable cause to believe his or her conduct was unlawful, (b)&nbsp;a transaction from which the director derived an improper personal benefit, either directly or indirectly,
(c)&nbsp;a circumstance under which the liability provisions of Section&nbsp;607.0834 are applicable, (d)&nbsp;in a proceeding by or in the right of the corporation to procure a judgment in its favor or by or in the right of a shareholder, conscious
disregard for the best interest of the corporation, or willful misconduct, or (e)&nbsp;in a proceeding by or in the right of someone other than the corporation or a shareholder, recklessness or an act or omission which was committed in bad faith or
with malicious purpose or in a manner exhibiting wanton and willful disregard of human rights, safety, or property. A judgment or other final adjudication against a director in any criminal proceeding for a violation of the criminal law estops that
director from contesting the fact that his or her breach, or failure to perform, constitutes a violation of the criminal law; but does not stop the director from establishing that he or she had reasonable cause to believe that his or her conduct was
lawful or had no reasonable cause to believe that his or her conduct was unlawful. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under Section&nbsp;607.0850(1) of the Florida Act, a
corporation has the power to indemnify any person who was or is a party to any proceeding (other than an action by, or in the right of the corporation), by reason of the fact that he or she is or was a director, officer, employee or agent of the
corporation or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against liability incurred in connection with such proceeding,
including any appeal thereof, if he or she acted in good faith and in a manner he or she reasonably believed to be in, or not opposed to, the best interests of the corporation and, with respect to any criminal action or proceeding, had no reasonable
cause to believe his or her conduct was unlawful. The termination of any proceeding by judgment, order, settlement or conviction or upon a plea of nolo contendere or its equivalent shall not, of itself, create a presumption that the person did not
act in good faith and in a manner which he or she reasonably believed to be in, or not opposed to, the best interests of the corporation or, with respect to any criminal action or proceeding, has reasonable cause to believe that his or her conduct
was unlawful. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under Section&nbsp;607.0850(2) of the Florida Act, a corporation has the power to indemnify any person, who was or is a
party to any proceeding by or in the right of the corporation to procure a judgment in its favor by reason of the fact that the person is or was a director, officer, employee, or agent of the corporation or is or was serving at the request of the
corporation as a director, officer, employee, or agent of another corporation, partnership, joint venture, trust, or other enterprise, against expenses and amounts paid in settlement not exceeding, in the judgment of the board of directors, the
estimated expense of litigating the proceeding to conclusion, actually and reasonably incurred in connection with the defense or settlement of such proceeding, including any appeal thereof. Such indemnification shall be authorized if such person
acted in good faith and in a manner he or she reasonably believed to be in, or not opposed to, the best interests of the corporation, except that no indemnification shall be made under this subsection in respect of any claim, issue, or matter as to
which such person shall have been adjudged to be liable unless, and only to the extent that, the court in which such proceeding was brought, or any other court of competent jurisdiction, shall determine upon application that, despite the
adjudication of liability but in view of all circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which such court shall deem proper. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, under Section&nbsp;607.0850(3) of the Florida Act, to the extent that a director, officer, employee or agent of the corporation
has been successful on the merits or otherwise in defense of any proceeding referred to in Sections 607.0850(1) or 607.0850(2) described above, or in defense of any claim, issue, or matter therein, he or she shall be indemnified against expenses
actually and reasonably incurred by him or her in connection therewith. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">II-2</FONT> </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under Section&nbsp;607.0850 of the Florida Act, the indemnification and advancement of
expenses provided pursuant to Section&nbsp;607.0850 of the Florida Act are not exclusive, and a corporation may make any other or further indemnification or advancement of expenses of any of its directors, officers, employees, or agents, under any
bylaw, agreement, vote of shareholders or disinterested directors, or otherwise, both as to action in his or her official capacity and as to action in another capacity while holding such office. However, indemnification or advancement of expenses
shall not be made to or on behalf of any director, officer, employee or agent if a judgment or other final adjudication establishes that his or her actions, or omissions to act, were material to the cause of action so adjudicated and constitute:
(a)&nbsp;a violation of the criminal law, unless the director, officer, employee or agent had reasonable cause to believe his or her conduct was unlawful; (b)&nbsp;a transaction from which the director, officer, employee or agent derived an improper
personal benefit; (c)&nbsp;in the case of a director, a circumstance under which the above liability provisions of Section&nbsp;607.0834 are applicable; or (d)&nbsp;willful misconduct or a conscious disregard for the best interests of the
corporation in a proceeding by or in the right of the corporation to procure a judgment in its favor or in a proceeding by or in the right of a shareholder. Our amended and restated articles of incorporation, as amended, provide that we shall
indemnify and may advance expenses to our officers and directors to the fullest extent permitted by the current law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;607.0850 also provides that a corporation shall have the power to purchase and maintain insurance on behalf of any person who is
or was a director, officer, employee or agent of the corporation against any liability asserted against the person and incurred by him or her in any such capacity or arising out of his status as such, whether or not the corporation would have the
power to indemnify him against such liability under the provisions of Section&nbsp;607.0850. We have secured insurance covering our directors and officers and those of our principal subsidiaries and affiliate companies against certain liabilities.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have entered into indemnification agreements with each member of our board of directors and our executive officers. The
indemnification agreements require, among other things, that we indemnify to the fullest extent permitted by law and advance to each indemnified director and executive officer all related expenses, subject to reimbursement if it is subsequently
determined that indemnification is not permitted. Under the indemnification agreements, we must also indemnify and advance all expenses incurred by an indemnified director or executive officer seeking to enforce his or her rights under the
indemnification agreements and purchase and generally maintain in effect directors&#146; and officers&#146; liability insurance during the term, and for a period of five years following the termination, of each director&#146;s and executive
officer&#146;s employment. Although the indemnification agreements offer substantially the same scope of coverage afforded by law, they provide greater assurance to directors and executive officers that indemnification will be available, because, as
contracts, they cannot be modified unilaterally in the future by the board of directors or the shareholders to eliminate the rights they provide. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;7. Exemption from Registration Claimed. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;8. Exhibits
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">See &#147;Exhibit Index&#148; on page <FONT STYLE="white-space:nowrap">II-5</FONT> below. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;9. Undertakings </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The undersigned registrant hereby undertakes: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To file, during any period in which offers or sales are being made, a post-effective amendment to this
registration statement: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To include any prospectus required by Section&nbsp;10(a)(3) of the Securities Act; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To reflect in the prospectus any facts or events arising after the effective date of the registration statement
(or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">II-3</FONT> </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="17%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would
not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in
volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the &#147;Calculation of Registration Fee&#148; table in the effective registration statement; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To include any material information with respect to the plan of distribution not previously disclosed in the
registration statement or any material change to such information in the registration statement; </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Provided,
however</I>, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the SEC by the registrant pursuant to
section 13 or section 15(d) of the Exchange Act that are incorporated by reference in this registration statement. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment
shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial <I>bona fide </I>offering thereof. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To remove from registration by means of a post-effective amendment any of the securities being registered which
remain unsold at the termination of the offering. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The undersigned registrant hereby undertakes that, for purposes of determining any liability under the
Securities Act, each filing of the registrant&#146;s annual report pursuant to section 13(a) or section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan&#146;s annual report pursuant to section 15(d) of the
Exchange Act) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the
initial bona fide offering thereof. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors,
officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act
and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the
successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been
settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">II-4</FONT> </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD WIDTH="91%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Exhibit<BR>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>4.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/893949/000119312514045903/d661956dex31.htm">Composite Articles of Incorporation of MEDNAX, Inc. (incorporated by reference to Exhibit 3.1 to MEDNAX&#146;s Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> for the period ended December&nbsp;31, 2013).</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>4.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/893949/000119312518319651/d651142dex31.htm">Amended and Restated Bylaws of MEDNAX, Inc. (incorporated by reference to Exhibit 3.1 to MEDNAX&#146;s Current Report on Form <FONT
STYLE="white-space:nowrap">8-K</FONT> filed with the SEC on November&nbsp;6, 2018).</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>5.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d754061dex51.htm">Opinion of DLA Piper LLP (US). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/893949/000119312519092753/d716213ddef14a.htm">MEDNAX, Inc. Amended and Restated 2008 Incentive Compensation Plan (incorporated by reference to Exhibit A to MEDNAX&#146;s Definitive Proxy
 Statement on Schedule 14A, filed with the SEC on March&nbsp;29, 2019).</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d754061dex231.htm">Consent of PricewaterhouseCoopers LLP. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d754061dex51.htm">Consent of DLA Piper LLP (US) (contained in its opinion filed as Exhibit 5.1 hereto). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>24.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="#sig">Power of Attorney (contained on the signature pages of this Registration Statement). </A></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">II-5</FONT> </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets
all of the requirements for filing on Form <FONT STYLE="white-space:nowrap">S-8</FONT> and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Sunrise, State of Florida
on this 30th day of May, 2019. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>MEDNAX, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Roger J. Medel, M.D.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Roger J. Medel, M.D.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Chief Executive
Officer</P></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">II-6</FONT> </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="sig"></A>POWER OF ATTORNEY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each person whose signature appears below hereby appoints Roger J. Medel, M.D., Dominic J. Andreano and Stephen D. Farber such person&#146;s
true and lawful <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorney-in-fact,</FONT></FONT> each acting alone, with full powers of substitution and resubstitution, with authority to execute in the name of each such person, and
to file with the SEC, together with any exhibits thereto and other documents therewith, any and all amendments (including without limitation post-effective amendments) to this registration statement necessary or advisable to enable the registrant to
comply with the Securities Act of 1933, as amended, and any rules, regulations and requirements of the SEC in respect thereof, which amendments may make such other changes in the registration statement as the aforesaid
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorney-in-fact</FONT></FONT> executing the same deems appropriate. Pursuant to the requirements of the Act, this registration statement has been signed below by the following
persons in the capacities and on the dates indicated. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="37%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="15%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Signature</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Title</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Date</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Roger J. Medel, M.D.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Roger J. Medel, M.D</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Chief Executive Officer and Director</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Principal Executive Officer)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">May&nbsp;30, 2019</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Stephen D. Farber</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Stephen D. Farber</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Chief Financial Officer</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Principal Financial Officer)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">May&nbsp;30, 2019</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ John C. Pepia</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">John C. Pepia</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Chief Accounting Officer</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Principal Accounting Officer)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">May&nbsp;30, 2019</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Cesar L. Alvarez</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Cesar L. Alvarez</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director and Chairman of the Board</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">May&nbsp;30, 2019</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Manuel Kadre</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Manuel Kadre</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Lead Independent Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">May&nbsp;30, 2019</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Karey D. Barker</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Karey D. Barker</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">May&nbsp;30, 2019</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Waldemar A. Carlo, M.D.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Waldemar A. Carlo, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">May&nbsp;30, 2019</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Michael B. Fernandez</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Michael B. Fernandez</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">May&nbsp;30, 2019</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Paul G. Gabos</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Paul G. Gabos</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">May&nbsp;30, 2019</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Pascal J. Goldschmidt, M.D.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Pascal J. Goldschmidt, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">May&nbsp;30, 2019</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Carlos A. Migoya</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Carlos A. Migoya</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">May&nbsp;30, 2019</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Michael A. Rucker</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Michael A. Rucker</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">May&nbsp;30, 2019</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Enrique J. Sosa, Ph.D.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Enrique J. Sosa, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">May&nbsp;30, 2019</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">II-7</FONT> </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>d754061dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit&nbsp;5.1 </B></P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:1pt">


<IMG SRC="g754061g62m39.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>DLA Piper LLP (US)</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">200 South Biscayne
Boulevard</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Suite 2500</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Miami, Florida 33131-5341</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">www.dlapiper.com</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>T</B> 305.423.8500</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>F</B> 305.437.8131</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">May&nbsp;30, 2019 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MEDNAX, Inc.
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1301 Concord Terrace </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sunrise, Florida 33323 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Re: Registration Statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> for the MEDNAX, Inc. Amended and Restated 2008 Incentive
Compensation Plan </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On or about the date hereof, MEDNAX, Inc., a Florida corporation (the &#147;Company&#148;), is filing with the Securities and Exchange
Commission (the &#147;Commission&#148;) a Registration Statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> (the &#147;Registration Statement&#148;), under the Securities Act of 1933, as amended (the &#147;Act&#148;). The Registration
Statement relates to the offering and sale by the Company of up to an additional 8,275,000 shares of the Company&#146;s common stock, par value $0.01 per share (the &#147;Common Stock&#148;), to be issued under the MEDNAX, Inc. Amended and Restated
2008 Incentive Compensation Plan (the &#147;Plan&#148;). We have acted as counsel to the Company in connection with the preparation and filing of the Registration Statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection therewith, we have examined and relied upon the original or a copy, certified to our satisfaction, of (i)&nbsp;the Amended and
Restated Articles of Incorporation and Amended and Restated Bylaws of the Company, each as amended to the date hereof; (ii)&nbsp;records of corporate proceedings of the Company related to the Plan; (iii)&nbsp;the Registration Statement and exhibits
thereto; and (iv)&nbsp;such other documents and instruments as we have deemed necessary for the expression of the opinions herein contained. In making the foregoing examinations, we have assumed the genuineness of all signatures and the authenticity
of all documents submitted to us as originals, and the conformity to original documents of all documents submitted to us as certified or photostatic copies. We have also assumed that the offer and sale of shares of Common Stock complies and will
comply in all respects with the terms, conditions and restrictions set forth in the Registration Statement and the Plan. As to various questions of fact material to this opinion, we have relied, to the extent we deemed reasonably appropriate, upon
representations of officers or directors of the Company and upon documents, records and instruments furnished to us by the Company, without independently checking or verifying the accuracy of such documents, records and instruments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based upon the foregoing examination, we are of the opinion that assuming that (i)&nbsp;the Company maintains an adequate number of authorized
and unissued shares of Common Stock available for issuance pursuant to the Plan and (ii)&nbsp;the consideration, if any, required to be paid in connection with the issuance of underlying shares of Common Stock issued pursuant to the Plan is actually
received by the Company as provided in the Plan, the shares of Common Stock issued pursuant to the Plan will be duly authorized, validly issued, fully paid and nonassessable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This opinion is rendered solely in connection with the transactions covered hereby. This opinion may not be relied upon for any other purpose,
without our prior written consent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We hereby consent to the filing of this opinion as an exhibit to the Registration Statement. In giving
such consent, we do not admit that we come within the category of persons whose consent is required by Section&nbsp;7 of the Act or the rules and regulations of the Commission thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The opinions expressed herein are specifically limited to the laws of the State of Florida and the federal laws of the United States of
America and speak only as of the date hereof. We assume no obligation to update or supplement such opinions to reflect any facts or circumstances that may hereafter come to our attention or any changes in law that may hereafter occur. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Sincerely,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">/s/ DLA Piper LLP (US)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"></TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>d754061dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-23.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit&nbsp;23.1 </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We hereby consent to the incorporation by reference in this Registration Statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> of MEDNAX, Inc. of our
report<SUP STYLE="font-size:85%; vertical-align:top"> </SUP>dated February&nbsp;14, 2019 relating to the financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appears in MEDNAX,
Inc.&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2018. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ PricewaterhouseCoopers LLP
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Miami, Florida </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">May&nbsp;30, 2019 </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g754061g62m39.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g754061g62m39.jpg
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_  !$( $D
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MJ% BXRDX"V?K%5?*VP/H<^V[,ZBEZ,1%Z[(FH:.C+RN].ZTS&Q2WH\!7X'C
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M9RX.2TZPZXVJBR./IY:A<QF1KA:HWZ[:MNNR.0:AP2# GCB1F1GD3&8,"B#
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0G&FG&FG&FG&FG&FG&FO_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
